120 related articles for article (PubMed ID: 22372972)
1. Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.
Pruss CM; Golder M; Bryant A; Hegadorn C; Haberichter S; Lillicrap D
J Thromb Haemost; 2012 May; 10(5):940-50. PubMed ID: 22372972
[TBL] [Abstract][Full Text] [Related]
2. Essential domains of a disintegrin and metalloprotease with thrombospondin type 1 repeats-13 metalloprotease required for modulation of arterial thrombosis.
Xiao J; Jin SY; Xue J; Sorvillo N; Voorberg J; Zheng XL
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2261-9. PubMed ID: 21799176
[TBL] [Abstract][Full Text] [Related]
3. Mutation G1629E Increases von Willebrand Factor Cleavage via a Cooperative Destabilization Mechanism.
Aponte-Santamaría C; Lippok S; Mittag JJ; Obser T; Schneppenheim R; Baldauf C; Gräter F; Budde U; Rädler JO
Biophys J; 2017 Jan; 112(1):57-65. PubMed ID: 28076816
[TBL] [Abstract][Full Text] [Related]
4. An IAP retrotransposon in the mouse ADAMTS13 gene creates ADAMTS13 variant proteins that are less effective in cleaving von Willebrand factor multimers.
Zhou W; Bouhassira EE; Tsai HM
Blood; 2007 Aug; 110(3):886-93. PubMed ID: 17426255
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance.
Ozel AB; McGee B; Siemieniak D; Jacobi PM; Haberichter SL; Brody LC; Mills JL; Molloy AM; Ginsburg D; Li JZ; Desch KC
J Thromb Haemost; 2016 Sep; 14(9):1888-98. PubMed ID: 27359253
[TBL] [Abstract][Full Text] [Related]
6. Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition.
Larkin D; de Laat B; Jenkins PV; Bunn J; Craig AG; Terraube V; Preston RJ; Donkor C; Grau GE; van Mourik JA; O'Donnell JS
PLoS Pathog; 2009 Mar; 5(3):e1000349. PubMed ID: 19300493
[TBL] [Abstract][Full Text] [Related]
7. ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation.
Deconinck SJ; Nix C; Barth S; Bennek-Schöpping E; Rauch A; Schelpe AS; Roose E; Feys HB; Pareyn I; Vandenbulcke A; Muia J; Vandenbriele C; Susen S; Meyns B; Tersteeg C; Jacobs S; De Meyer SF; Vanhoorelbeke K
J Thromb Haemost; 2022 Dec; 20(12):2797-2809. PubMed ID: 36128768
[TBL] [Abstract][Full Text] [Related]
8. Molecular Imaging of VWF (von Willebrand Factor) and Platelet Adhesion in Postischemic Impaired Microvascular Reflow.
Ozawa K; Packwood W; Varlamov O; Qi Y; Xie A; Wu MD; Ruggeri Z; López JA; Lindner JR
Circ Cardiovasc Imaging; 2018 Nov; 11(11):e007913. PubMed ID: 30571316
[TBL] [Abstract][Full Text] [Related]
9. Cleavage of the ADAMTS13 propeptide is not required for protease activity.
Majerus EM; Zheng X; Tuley EA; Sadler JE
J Biol Chem; 2003 Nov; 278(47):46643-8. PubMed ID: 12975358
[TBL] [Abstract][Full Text] [Related]
10. Impact of allele-selective silencing of von Willebrand factor in mice based on a single nucleotide allelic difference in von Willebrand factor.
Jongejan YK; Linthorst NA; Schrader Echeverri E; Laan SNJ; Dirven RJ; Dahlman JE; van Vlijmen BJM; Denis CV; Eikenboom JCJ
Thromb Res; 2024 Apr; 236():201-208. PubMed ID: 38461614
[TBL] [Abstract][Full Text] [Related]
11. Unconjugated bilirubin inhibits proteolytic cleavage of von Willebrand factor by ADAMTS13 protease.
Lu RN; Yang S; Wu HM; Zheng XL
J Thromb Haemost; 2015 Jun; 13(6):1064-72. PubMed ID: 25782102
[TBL] [Abstract][Full Text] [Related]
12. The Role of Platelets and von Willebrand Factor in the Procoagulant Phenotype of Inflammatory Bowel Disease.
Schellenberg C; Lagrange J; Ahmed MU; Arnone D; Campoli P; Louis H; Touly N; Caron B; Plénat F; Perrin J; Lenting PJ; Regnault V; Lacolley P; Denis CV; Peyrin-Biroulet L
J Crohns Colitis; 2024 May; 18(5):751-761. PubMed ID: 38011752
[TBL] [Abstract][Full Text] [Related]
13. Dynamic and functional linkage between von Willebrand factor and ADAMTS-13 with aging: an Atherosclerosis Risk in Community study.
Liu W; Patel K; Wang Y; Nodzenski M; Nguyen A; Teramura G; Higgins HA; Hoogeveen RC; Couper D; Fu X; Konkle BA; Loop MS; Dong JF
J Thromb Haemost; 2023 Dec; 21(12):3371-3382. PubMed ID: 37574196
[TBL] [Abstract][Full Text] [Related]
14. In vivo analysis of the role of O-glycosylations of von Willebrand factor.
Badirou I; Kurdi M; Legendre P; Rayes J; Bryckaert M; Casari C; Lenting PJ; Christophe OD; Denis CV
PLoS One; 2012; 7(5):e37508. PubMed ID: 22616016
[TBL] [Abstract][Full Text] [Related]
15. Novel Thrombotic Function of a Human SNP in STXBP5 Revealed by CRISPR/Cas9 Gene Editing in Mice.
Zhu QM; Ko KA; Ture S; Mastrangelo MA; Chen MH; Johnson AD; O'Donnell CJ; Morrell CN; Miano JM; Lowenstein CJ
Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):264-270. PubMed ID: 28062498
[TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein promotes microvascular thrombosis by enhancing von Willebrand factor self-association.
Chung DW; Platten K; Ozawa K; Adili R; Pamir N; Nussdorfer F; St John A; Ling M; Le J; Harris J; Rhoads N; Wang Y; Fu X; Chen J; Fazio S; Lindner JR; López JA
Blood; 2023 Sep; 142(13):1156-1166. PubMed ID: 37506337
[TBL] [Abstract][Full Text] [Related]
17. Plasma and rhADAMTS13 reduce trauma-induced organ failure by restoring the ADAMTS13-VWF axis.
Kleinveld DJB; Simons DDG; Dekimpe C; Deconinck SJ; Sloos PH; Maas MAW; Kers J; Muia J; Brohi K; Voorberg J; Vanhoorelbeke K; Hollmann MW; Juffermans NP;
Blood Adv; 2021 Sep; 5(17):3478-3491. PubMed ID: 34505883
[TBL] [Abstract][Full Text] [Related]
18. Numerical study of ultra-large von Willebrand factor multimers in coagulopathy.
Rahmati N; Keshavarz Motamed P; Maftoon N
Biomech Model Mechanobiol; 2024 Jun; 23(3):737-756. PubMed ID: 38217745
[TBL] [Abstract][Full Text] [Related]
19. VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis.
Asada S; Namisaki T; Kaji K; Takaya H; Kubo T; Akahane T; Kawaratani H; Nishimura N; Takeda S; Masuda H; Shibamoto A; Inoue T; Iwai S; Tomooka F; Tsuji Y; Fujinaga Y; Kitagawa K; Mitoro A; Sato S; Matsumoto M; Yoshiji H
Dig Dis Sci; 2024 Mar; 69(3):851-869. PubMed ID: 38244124
[TBL] [Abstract][Full Text] [Related]
20. Removal of endothelial surface-associated von villebrand factor suppresses accelerate datherosclerosis after myocardial infarction.
Ozawa K; Packwood W; Muller MA; Qi Y; Xie A; Varlamov O; McCarty OJ; Chung D; López JA; Lindner JR
J Transl Med; 2024 May; 22(1):412. PubMed ID: 38693516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
